Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06744660 · ClinicalTrials.gov registry record · NA
Clinical Validation of the Aptitude Medical Systems Metrix COVID-19 Test
A NA study of COVID-19 and COVID, sponsored by Aptitude Medical Systems.
- Recruiting
- Registry status
- NA
- Development phase
- 1,000
- Enrollment target
- 3
- Study locations
NCT06744660 is a NA study of COVID-19 and COVID that is actively recruiting participants, run by Aptitude Medical Systems. The registered enrollment target is 1,000 participants, below the 55,210-participant average among 203 other COVID-19 trials with a reported enrollment target (98% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT06744660, a NA study of COVID-19 and COVID, is actively recruiting participants, sponsored by Aptitude Medical Systems.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,000 participants
- Enrollment target
- 3
- Study locations
Study Summary
The Metrix COVID Test will be evaluated for use in Point-of-Care and Non-Laboratory settings in a home testing environment utilizing the clinical study design described herein. The study will take place in simulated home environments which will be set up within or near active clinical settings (e.g., urgent care facilities). This will be a prospective study conducted at three or more investigational sites located within the United States for the clinical validation of the Metrix COVID Test for the detection of SARS-CoV-2 AN swab samples. Additional sites may be added to the study in order to meet minimum subject/sample enrollment requirements and geographic prevalence of respiratory virus infections. Comparator testing will be performed to determine the infection status of each sample for comparison to results generated by the candidate test. The primary comparator for the study will be an FDA-cleared assay for the detection of SARS-CoV-2.
Interventions
- DIAGNOSTIC_TEST Aptitude Medical Systems Metrix COVID Test
Study Locations (3)
Alabama
- AFC Montclair - Birmingham
- AFC Madison - Madison
Louisiana
- PPU Mid City - Baton Rouge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2024-10-17 |
| Est. Completion | 2025-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06744660
The ClinicalTrials.gov registry entry for NCT06744660 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,210-participant average among 203 other COVID-19 trials with a reported enrollment target (98% lower). The listed sponsor is Aptitude Medical Systems, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which Aptitude Medical Systems Metrix COVID Test is the first listed.
NCT06744660 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Alabama, Louisiana.
Frequently Asked Questions
What is clinical trial NCT06744660 about?
NCT06744660 is a clinical study titled "Clinical Validation of the Aptitude Medical Systems Metrix COVID-19 Test". The Metrix COVID Test will be evaluated for use in Point-of-Care and Non-Laboratory settings in a home testing environment utilizing the clinical study design described herein. The study will take place in simulated home environments which will be set up within or near active clinical settings (e.g....
What is the current status of trial NCT06744660?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2024-10-17. Estimated completion is 2025-12-01.
What conditions does trial NCT06744660 study?
This clinical trial studies the following conditions: COVID-19, COVID.
What interventions are being tested in trial NCT06744660?
The interventions under investigation include: Aptitude Medical Systems Metrix COVID Test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06744660?
This trial is sponsored by Aptitude Medical Systems, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06744660 being conducted?
This trial has 3 study locations across Alabama, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Music Mindfulness Study 2a.
RECRUITING · NA
-
Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)
RECRUITING · NA
-
Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
RECRUITING · NA
-
Evaluating the Impact of Social Music
RECRUITING · NA
-
The SINCERE Intervention to Address COVID-19 Health Disparities
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.